Skip to main content

Table 1 Clinical characteristics data of the study population

From: Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation

Characteristics

Sample (n = 97)

Gender, n (%)

 Male

57 (58.8)

 Female

40 (41.2)

Age, mean (SD)

60.4 (46.6)

Risk factor, n (%)

 Malignancy

25 (25.8)

 Immobility

15 (15.5)

 Sepsis

2 (2.1)

 Trauma

2 (2.1)

 Cardiac arrythmia

1 (1)

 Hormonal treatment

1 (1)

 Obesity

1 (1)

 Pregnancy

0 (0)

Follow-up time, median (min-max) days

141 (74–192)

Treatment, n (%)

 LMWH followed by VKAs

37 (38.1)

 VKAs alone

60 (61.9)

  1. DVT Deep vein thrombosis, LMWH Low molecular weight heparin, LMWH Low molecular weight heparin, VKAs Vitamin K antagonists